'Unnecessarily complicated': Draft EU template on GMP standards for investigational drugs
This article was originally published in SRA
Executive Summary
Parts of the new EU template for qualified persons to certify that investigational drugs from non-EU countries comply with good manufacturing practice standards are "unnecessarily complicated" and lack clarity, according to research-based EU pharma industry federation EFPIA1.